[A comparative analysis of the efficacy of two vitamin D supplementation regimens in preterm infants: a prospective

Li Ma1, Li-Meng Geng, Xi-Hui Zhou

  • 1Department of Neonatology, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, China. zhouxih@mail.xjtu.edu.cn.

Insights

A single intramuscular vitamin D injection significantly improved vitamin D levels in preterm infants by day 28. This method effectively reduced vitamin D deficiency without adverse effects.

Area of Science:

  • Neonatal Medicine
  • Pediatric Nutrition
  • Endocrinology

Background:

  • Preterm infants (<34 weeks gestation) are at high risk for vitamin D deficiency.
  • Establishing optimal vitamin D supplementation for this vulnerable population is crucial for their nutritional status and long-term health.

Purpose of the Study:

  • To compare the efficacy of a single intramuscular vitamin D3 injection versus daily oral vitamin D3 drops on serum 25-hydroxyvitamin D [25(OH)D] levels in preterm infants.
  • To assess the prevalence of vitamin D deficiency and the safety of different supplementation regimens.

Main Methods:

  • 59 preterm infants (<34 weeks gestation) were divided into two groups.
  • Observation group: Single intramuscular dose of vitamin D3 (10,000 IU/kg).
  • Control group: Oral vitamin D3 drops (900 IU/d) for 25 days. Serum 25(OH)D levels were measured at birth and on day 28.

Main Results:

  • Initial vitamin D deficiency prevalence was 78% in all infants.
  • On day 28, the intramuscular group showed significantly higher serum 25(OH)D levels compared to the oral group.
  • The intramuscular injection significantly reduced the prevalence of vitamin D deficiency, with no reported overdose or toxicity.

Conclusions:

  • A single intramuscular dose of 10,000 IU/kg vitamin D3 is a safe and effective strategy.
  • This regimen significantly improves vitamin D nutritional status in preterm infants by day 28.
  • Intramuscular vitamin D supplementation offers a promising alternative for preventing deficiency in this population.
Abstract

Related Concept Videos

Bioavailability Study Design: Single Versus Multiple Dose Studies01:11

Bioavailability Study Design: Single Versus Multiple Dose Studies

Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...
101
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
133
Role of Skin in Vitamin D Synthesis01:23

Role of Skin in Vitamin D Synthesis

The skin plays a crucial role in the synthesis of vitamin D, a vital nutrient for various physiological processes in the body. Vitamin D is unique because it can be synthesized in the skin through a series of chemical reactions triggered by exposure to ultraviolet B (UVB) radiation from sunlight.
The solar UV B rays (290-315 nm) are absorbed by the skin, and 7-dehydrocholesterol (provitamin D3) photolyzes it to previtamin D3, which undergoes a rapid transformation to vitamin...
7.2K
Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
69
Bioavailability Study Design: Absolute Versus Relative Bioavailability01:27

Bioavailability Study Design: Absolute Versus Relative Bioavailability

Bioavailability is a crucial pharmacokinetic parameter that quantifies the proportion of an administered drug that reaches the systemic circulation and is available for therapeutic action. Regulatory agencies mandate the assessment of bioavailability, typically measured as the area under the drug plasma concentration-versus-time curve (AUC), to ensure the efficacy and safety of pharmaceutical products. These evaluations are categorized as absolute and relative bioavailability studies.Absolute...
161
Study Designs in Epidemiology01:20

Study Designs in Epidemiology

Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
693